arginine has been researched along with Dementia Praecox in 53 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (5.66) | 18.7374 |
| 1990's | 3 (5.66) | 18.2507 |
| 2000's | 11 (20.75) | 29.6817 |
| 2010's | 26 (49.06) | 24.3611 |
| 2020's | 10 (18.87) | 2.80 |
| Authors | Studies |
|---|---|
| Cieślik, P; Kalinowski, L; Wierońska, JM | 1 |
| Fan, Y; Gao, F; Ma, Q; Ma, X; Wang, C; Wang, W; Wang, Y; Xi, W; Zhao, B; Zhou, L; Zhu, F | 1 |
| Chen, YY; Chou, YH; Liu, MN; Yang, BH; Yang, KC | 1 |
| Deane, AR; Jing, Y; Liu, P; Shoorangiz, R; Ward, RD | 1 |
| Arai, M; Iino, K; Itokawa, M; Kamiguchi, H; Miyashita, M; Nagai, R; Nishida, A; Ozawa, A; Sugawa, H; Suzuki, K; Tabata, K; Toriumi, K; Usami, S; Yamaguchi, S; Yamasaki, S | 1 |
| Bilici, M; Gencer, AG; Oral, E; Ozcan, H; Uğur, K; Ustundag, MF; Yilmaz, ED | 1 |
| Fan, X; Oh, SJ | 1 |
| Balenovic, I; Blagaic, AB; Cilic, M; Drmic, D; Filipcic, I; Ilic, S; Kokot, A; Seiwerth, S; Sikiric, P; Strbe, S; Tvrdeic, A; Vukojevic, J; Zemba Cilic, A; Zemba, M; Zoricic, Z | 1 |
| Braun, D; Haen, E; Schlossmann, J | 1 |
| Arai, H; Arai, M; Horiuchi, Y; Imai, A; Itokawa, M; Kobori, A; Miyano, Y; Miyashita, M; Nagase, Y; Niizato, K; Nishida, A; Oshima, K; Suzuki, K; Takizawa, S; Toriumi, K; Usami, S; Yamasaki, S; Yoshikawa, A | 1 |
| Amano, N; Arai, M; Dan, T; Horiuchi, Y; Ichikawa, T; Ishimoto, K; Itokawa, M; Kobori, A; Miyashita, M; Miyata, T; Okazaki, Y; Takahashi, K; Tokunaga, T; Toriumi, K; Usami, S; Washizuka, S; Yoshikawa, T | 1 |
| Ayhan, Y; Karahan, S; Koçyiğit, Y; Yazıcı, MK; Yoca, G | 1 |
| Arai, H; Hasegawa, T; Hirose, H; Ikeda, S; Katsuta, N; Komiyama, E; Mao, W; Miki, Y; Nakadaira, M; Nakayama, K; Nishimon, S; Ohnuma, T; Orimo, N; Suga, Y; Takebayashi, Y; Tani, E; Yamashita, H | 1 |
| Amano, N; Arai, M; Ichikawa, T; Itokawa, M; Kobori, A; Miyashita, M; Miyata, T; Niizato, K; Okazaki, Y; Oshima, K; Toriumi, K; Yoshikawa, T | 1 |
| Amano, N; Arai, M; Arinami, T; Fukumoto, M; Hashimoto, R; Itokawa, M; Kasai, K; Koike, S; Kushima, I; Miyashita, M; Miyata, T; Niizato, K; Okazaki, Y; Oshima, K; Ozaki, N; Takeda, M; Toyota, T; Ujike, H; Yoshikawa, T; Yuzawa, H | 1 |
| Arai, H; Hanzawa, R; Higa, M; Higashiyama, R; Hotta, Y; Katsuta, N; Maeshima, H; Nakamura, T; Nishimon, S; Ohnuma, T; Sannohe, T; Shibata, N; Takebayashi, Y; Takeda, M | 1 |
| Arai, M; Horiuchi, Y; Itokawa, M; Kobori, A; Miyashita, M; Toriumi, K | 1 |
| Ak, M; Celik, C; Doruk, A; Erdem, M; Garip, B; Karaahmetoğlu, B; Yükselir, C; Zincir, S; Zincir, SB | 1 |
| Fink-Jensen, A; Jorgensen, A; Jorgensen, MB; Knorr, U; Lykkesfeldt, J; Olsen, NV; Poulsen, HE; Soendergaard, MG; Staalsø, JM | 1 |
| Aparci, M; Balta, S; Bolu, A; Kurtoglu, E; Ozturk, C | 1 |
| Zincir, S | 1 |
| Arai, M; Horiuchi, Y; Itokawa, M; Kayama, T; Kobori, A; Koike, S; Miyashita, M; Ogasawara, Y | 1 |
| Akiyama, K; Fujii, K; Homma, H; Katane, M; Miyamoto, T; Nonaka-Hashida, S; Ozeki, Y; Saitoh, Y; Sekine, M; Shimoda, K; Tsunoda, M | 1 |
| Dursun, SM; Hallak, JE; Kandratavicius, L; Machado-de-Sousa, JP; Maia-de-Oliveira, JP; Nunes, EA | 1 |
| Bilkey, DK; Collie, ND; Dean, B; Jing, Y; Liu, P; Zhang, H | 1 |
| Fleszar, MG; Frydecka, D; Misiak, B; Wiśniewski, J | 1 |
| Chen, HB; Hu, MR; Wei, B; Xiong, JW; Yan, K; Yang, YJ; Yu, B; Zhan, JQ; Zhao, Y | 1 |
| Arai, H; Gohda, T; Higashiyama, R; Katsuta, N; Kimoto, A; Miki, Y; Nakamura, T; Nishimon, S; Ohnuma, T; Sannohe, T; Shibata, N; Suzuki, Y; Takebayashi, Y; Takeda, M; Takeuchi, M; Tani, E; Tomino, Y; Yamagishi, SI | 1 |
| Hovorková, P; Klaschka, J; Kozmiková, I; Kristofiková, Z; Majer, E; Rícný, J; Rípová, D; Zach, P | 1 |
| Derakhshandeh, S; Farrashbandi, H; Saadat, I; Saadat, M | 1 |
| Baker, GB; Barger, SW; Labrie, V; Roder, JC; Wang, W | 1 |
| Chrysanthou-Piterou, M; Havaki, S; Issidorides, MR; Kloukina-Pantazidou, I; Kontaxakis, VP; Papadimitriou, GN | 1 |
| Aikawa, Y; Arai, M; Furukawa, A; Haga, S; Hashimoto, K; Ichikawa, T; Itokawa, M; Iwayama, Y; Iyo, M; Izawa, R; Kuroda, O; Matsushita, M; Matsuzawa, D; Miyata, T; Mori, N; Nakamura, K; Niizato, K; Nishida, A; Nohara, I; Obata, N; Ohnishi, T; Okazaki, Y; Sora, I; Tanaka, Y; Toyota, T; Ujike, H; Yoshikawa, T; Yuzawa, H | 1 |
| Cichon, S; Deufel, T; Kiehntopf, M; Koch, K; Mühleisen, TW; Nenadic, I; Nöthen, MM; Reichenbach, JR; Rietschel, M; Roebel, M; Sauer, H; Schachtzabel, C; Schlösser, RG; Schultz, CC; Wagner, G | 1 |
| Akgul, EO; Balikci, A; Cayci, T; Celik, C; Ozdemir, B; Uzun, O; Yaman, H; Zincir, S | 1 |
| Arai, M; Arinami, T; Ichikawa, T; Itokawa, M; Iwayama, Y; Maekawa, M; Miyashita, M; Toyosima, M; Toyota, T; Yoshikawa, T | 1 |
| Chan, CH; Cheng, C; Chiu, HJ; Hwu, TM; Lan, TH; Liu, YR; Loh, el-W | 1 |
| Adamski, J; Giegling, I; Hartmann, AM; He, Y; Illig, T; Kahn, R; Li, Y; Prehn, C; Rujescu, D; Wang-Sattler, R; Xie, L; Yu, Z | 1 |
| Akyol, O; Herken, H; Kocyigit, A; Köylü, A; Savaş, HA; Tutkun, H; Vural, H; Yanik, M; Zoroglu, SS | 1 |
| Arias, B; Barrantes-Vidal, N; Catalán, R; Fañanás, L; Guitart, M; Papiol, S; Salgado, P | 1 |
| Hashimoto, R; Iwata, N; Kamijima, K; Kitajima, T; Kunugi, H; Ozaki, N; Suzuki, T; Tatsumi, M; Yamanouchi, Y; Yoshida, M | 1 |
| Boronow, J; Dickerson, F; Origoni, A; Stallings, C; Yolken, R | 1 |
| Albus, M; Aschauer, HN; Gasche, C; Hornik, K; Leisch, F; Maier, W; Murray, SS; Schloegelhofer, M; Schosser, A; Schwab, SG; Wildenauer, DB | 1 |
| Engel, JA; Fejgin, K; Klamer, D; Pålsson, E; Svensson, L; Wass, C | 1 |
| Clarke, S; Corvin, AP; Donohoe, G; Gill, M; Kenny, N; McGhee, KA; Morris, DW; Murphy, K; Robertson, IH | 1 |
| Chen, CH; Chen, JY; Lai, IC; Liao, DL; Liou, YJ; Wang, LH; Wang, YC | 1 |
| Puukka, M; Ruokonen, A; Similä, S; von Wendt, L | 1 |
| Das, I; de Belleroche, J; Hirsch, SR; Khan, NS; Puri, BK; Sooranna, SR | 1 |
| Doyle, CA; Slater, P | 1 |
| Das, I; Hirsch, SR; Khan, NS; Puri, BK | 1 |
| Hurlock, EC | 1 |
| Issidorides, MR; Stefanis, CN | 1 |
| Szilágyi, KA | 1 |
4 review(s) available for arginine and Dementia Praecox
| Article | Year |
|---|---|
Current understanding on the role of nitric oxide and therapeutic potential of NO supplementation in schizophrenia.
Topics: Arginine; Humans; Nitric Oxide; Schizophrenia | 2020 |
Carbonyl stress and schizophrenia.
Topics: Arginine; Biomarkers; Glycation End Products, Advanced; Humans; Lactoylglutathione Lyase; Lysine; Mutation; Psychiatric Status Rating Scales; Pyridoxal; Pyridoxamine; Schizophrenia; Stress, Physiological | 2014 |
Nitric Oxide's Involvement in the Spectrum of Psychotic Disorders.
Topics: Antipsychotic Agents; Arginine; Brain; Clinical Trials as Topic; Humans; Nitric Oxide; Nitric Oxide Synthase; Phosphodiesterase 5 Inhibitors; Psychotic Disorders; Schizophrenia; Sildenafil Citrate | 2016 |
Interferons: potential roles in affect.
Topics: Affect; Animals; Arginine; Circadian Rhythm; Interferons; Limbic System; Methylation; Mice; Mice, Knockout; Mood Disorders; Schizophrenia; Signal Transduction | 2001 |
2 trial(s) available for arginine and Dementia Praecox
| Article | Year |
|---|---|
[L-Arginine Add-On Treatment for Schizophrenia: A Randomized,Double-Blind, Placebo-Controlled, Crossover Study].
Topics: Administration, Oral; Adult; Antipsychotic Agents; Arginine; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Psychiatric Status Rating Scales; Schizophrenia; Treatment Outcome | 2018 |
Histochemical changes in the blood cells of schizophrenic patients under pimozide treatment.
Topics: Adolescent; Adult; Arginine; Chromatin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Histocytochemistry; Histones; Humans; Male; Middle Aged; Neutrophils; Pimozide; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenia, Disorganized; Schizophrenia, Paranoid | 1976 |
47 other study(ies) available for arginine and Dementia Praecox
| Article | Year |
|---|---|
Procognitive activity of nitric oxide inhibitors and donors in animal models.
Topics: Alzheimer Disease; Animals; Arginine; Cognitive Dysfunction; Dizocilpine Maleate; Enzyme Inhibitors; Male; Mice; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type I; Nitroso Compounds; Nootropic Agents; Open Field Test; Rotarod Performance Test; Schizophrenia; Scopolamine; Spermine | 2022 |
Characterizing serum amino acids in schizophrenic patients: Correlations with gut microbes.
Topics: Amino Acids; Arginine; Gastrointestinal Microbiome; Glutamine; Humans; Leucine; Methionine; Schizophrenia | 2022 |
Interactions between dopamine transporter and N-methyl-d-aspartate receptor-related amino acids on cognitive impairments in schizophrenia.
Topics: Amino Acids; Arginine; Aspartic Acid; Cognitive Dysfunction; Corpus Striatum; Cysteine; Dopamine; Dopamine Plasma Membrane Transport Proteins; gamma-Aminobutyric Acid; Glutamates; Humans; Methionine; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Tomography, Emission-Computed, Single-Photon; Tropanes | 2022 |
Cognitive and arginine metabolic correlates of temporal dysfunction in the MIA rat model of schizophrenia risk.
Topics: Animals; Arginine; Cognition; Cognitive Dysfunction; Disease Models, Animal; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Schizophrenia | 2023 |
Glucuronic acid is a novel source of pentosidine, associated with schizophrenia.
Topics: Arginine; Glucuronic Acid; Glycation End Products, Advanced; Humans; Lysine; Schizophrenia | 2023 |
Nitric oxide, asymmetric dimethylarginine, symmetric dimethylarginine and L-arginine levels in psychotic exacerbation of schizophrenia and bipolar disorder manic episode.
Topics: Arginine; Bipolar Disorder; Disease Progression; Humans; Nitric Oxide; Schizophrenia | 2020 |
Pentadecapeptide BPC 157 counteracts L-NAME-induced catalepsy. BPC 157, L-NAME, L-arginine, NO-relation, in the suited rat acute and chronic models resembling 'positive-like' symptoms of schizophrenia.
Topics: Amphetamine; Animals; Apomorphine; Arginine; Behavior, Animal; Catalepsy; Disease Models, Animal; Dizocilpine Maleate; Dopamine Agents; Enzyme Inhibitors; Haloperidol; Male; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peptide Fragments; Proteins; Rats; Rats, Wistar; Schizophrenia | 2021 |
Asymmetric dimethylarginine in psychiatric disorders.
Topics: Arginine; Bipolar Disorder; Female; Humans; Male; Psychotic Disorders; Schizophrenia | 2021 |
Advanced glycation end products and cognitive impairment in schizophrenia.
Topics: Arginine; Cognition; Cognitive Dysfunction; Cross-Sectional Studies; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Neuropsychological Tests; Receptor for Advanced Glycation End Products; Schizophrenia | 2021 |
Pyridoxamine: A novel treatment for schizophrenia with enhanced carbonyl stress.
Topics: Adult; Antipsychotic Agents; Arginine; Drug Therapy, Combination; Female; Humans; Lactoylglutathione Lyase; Lysine; Male; Middle Aged; Outcome Assessment, Health Care; Oxidative Stress; Pyridoxamine; Schizophrenia; Vitamin B Complex | 2018 |
Skin advanced glycation end products as biomarkers of photosensitivity in schizophrenia.
Topics: Adult; Antipsychotic Agents; Arginine; Biomarkers; Case-Control Studies; Female; Fluorometry; Glycation End Products, Advanced; Humans; Lysine; Male; Photosensitivity Disorders; Pyridoxal; Schizophrenia; Skin; Ultraviolet Rays | 2019 |
Clinical features of schizophrenia with enhanced carbonyl stress.
Topics: Adult; Antipsychotic Agents; Arginine; Biomarkers; Female; Hospitalization; Humans; Lysine; Male; Middle Aged; Protein Carbonylation; Schizophrenia; Vitamin B 6 | 2014 |
Replication of enhanced carbonyl stress in a subpopulation of schizophrenia.
Topics: Arginine; Biomarkers; Case-Control Studies; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Metabolic Diseases; Pyridoxal; Schizophrenia; Stress, Physiological | 2014 |
Significance of measurements of peripheral carbonyl stress markers in a cross-sectional and longitudinal study in patients with acute-stage schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Arginine; Biomarkers; Cross-Sectional Studies; Female; Humans; Longitudinal Studies; Lysine; Male; Middle Aged; Pyridoxal; Schizophrenia; Treatment Outcome; Young Adult | 2014 |
Asymmetric dimethylarginine (ADMA) and treatment response relationship in male patients with first-episode schizophrenia: a controlled study.
Topics: Adult; Antipsychotic Agents; Arginine; Humans; Male; Middle Aged; Nitric Oxide; Schizophrenia; Treatment Outcome; Young Adult | 2014 |
Asymmetric dimethylarginine in somatically healthy schizophrenia patients treated with atypical antipsychotics: a case-control study.
Topics: Adult; Antipsychotic Agents; Arginine; Biomarkers; Case-Control Studies; Chromatography, High Pressure Liquid; Female; Humans; Male; Oxidative Stress; Schizophrenia | 2015 |
Asymmetric dimethylarginine levels in patients with schizophrenia.
Topics: Antipsychotic Agents; Arginine; Humans; Male; Nitric Oxide; Schizophrenia | 2015 |
Asymmetric dimethylarginine (ADMA) and treatment response relationship in male patients with first-episode schizophrenia: Author׳s reply.
Topics: Antipsychotic Agents; Arginine; Humans; Male; Nitric Oxide; Schizophrenia | 2015 |
Characterization of modified proteins in plasma from a subtype of schizophrenia based on carbonyl stress: Protein carbonyl is a possible biomarker of psychiatric disorders.
Topics: Adult; Antibodies, Monoclonal; Arginine; Biomarkers; Blood Proteins; Case-Control Studies; Female; Glycation End Products, Advanced; Humans; Immunoglobulin G; Lysine; Male; Middle Aged; Ornithine; Protein Carbonylation; Pyrimidines; Schizophrenia; Serum Albumin; Vitamin B 6; Vitamin B 6 Deficiency | 2015 |
Plasma concentrations of three methylated arginines, endogenous nitric oxide synthase inhibitors, in schizophrenic patients undergoing antipsychotic drug treatment.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Arginine; Female; Humans; Male; Middle Aged; Nitric Oxide Synthase; omega-N-Methylarginine; Schizophrenia; Treatment Outcome; Young Adult | 2016 |
Altered brain arginine metabolism in schizophrenia.
Topics: Agmatine; Arginase; Arginine; Autopsy; Blotting, Western; Brain; Case-Control Studies; Chromatography, High Pressure Liquid; Chromatography, Liquid; Citrulline; Female; Frontal Lobe; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Male; Mass Spectrometry; Middle Aged; Nitric Oxide Synthase Type III; Ornithine; Regression Analysis; Schizophrenia | 2016 |
Alterations in l-arginine metabolism in first-episode schizophrenia patients: Further evidence for early metabolic dysregulation.
Topics: Arginine; Humans; Schizophrenia | 2016 |
Increased plasma asymmetric dimethylarginine is associated with cognitive deficits in patients with schizophrenia.
Topics: Adult; Arginine; Biomarkers; Cognition Disorders; Cognitive Dysfunction; Female; Humans; Male; Neuropsychological Tests; Schizophrenia; Young Adult | 2016 |
High doses of antipsychotic polypharmacy are related to an increase in serum levels of pentosidine in patients with schizophrenia.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Arginine; Cross-Sectional Studies; Female; Humans; Lysine; Male; Middle Aged; Polypharmacy; Schizophrenia; Young Adult | 2017 |
Lateralization of hippocampal nitric oxide mediator system in people with Alzheimer disease, multi-infarct dementia and schizophrenia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Arginine; Citrulline; Dementia, Multi-Infarct; Female; Functional Laterality; Glutamine; Hippocampus; Humans; Isoenzymes; Male; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Schizophrenia; Signal Transduction | 2008 |
Association between genetic polymorphism of XRCC1 Arg194Trp and risk of schizophrenia.
Topics: Arginine; Case-Control Studies; Chi-Square Distribution; DNA-Binding Proteins; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Polymorphism, Single Nucleotide; Risk Factors; Schizophrenia; Tryptophan; X-ray Repair Cross Complementing Protein 1 | 2009 |
Genetic loss of D-amino acid oxidase activity reverses schizophrenia-like phenotypes in mice.
Topics: Animals; Arginine; Asparagine; Aspartic Acid; Behavior, Animal; Binding Sites; Carrier Proteins; D-Amino-Acid Oxidase; Female; Glycine; Male; Mice; Mutation; Nerve Tissue Proteins; Nervous System; Phenotype; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Schizophrenic Psychology; Serine; Social Behavior; Stereoisomerism | 2010 |
Chromatin alterations in leukocytes of first-episode schizophrenic patients.
Topics: Adolescent; Adult; Arginine; Biomarkers; Cell Nucleus; Chromatin; Female; Humans; Image Processing, Computer-Assisted; Leukocytes; Lysine; Male; Microscopy, Electron, Transmission; Middle Aged; Neutrophils; Schizophrenia; Silver Staining; Young Adult | 2010 |
Enhanced carbonyl stress in a subpopulation of schizophrenia.
Topics: Arginine; Biomarkers; Chromatography, High Pressure Liquid; Female; Glycation End Products, Advanced; Humans; Lactoylglutathione Lyase; Lysine; Male; Middle Aged; Oxidative Stress; Schizophrenia; Vitamin B 6 | 2010 |
Reduced cortical thickness is associated with the glutamatergic regulatory gene risk variant DAOA Arg30Lys in schizophrenia.
Topics: Adult; Arginine; Carrier Proteins; Cerebral Cortex; Female; Genetic Association Studies; Genetic Predisposition to Disease; Genetic Variation; Glutamic Acid; Humans; Intracellular Signaling Peptides and Proteins; Lysine; Male; Polymorphism, Genetic; Schizophrenia; Young Adult | 2011 |
Plasma asymmetric dimethylarginine (ADMA) concentrations in patients with first and multiple episode schizophrenia.
Topics: Adult; Arginine; Chromatography, High Pressure Liquid; Humans; Male; Psychiatric Status Rating Scales; Schizophrenia; Statistics, Nonparametric; Young Adult | 2011 |
Schizophrenia with the 22q11.2 deletion and additional genetic defects: case history.
Topics: Adult; Arginine; Chromosome Deletion; Chromosomes, Human, Pair 22; DiGeorge Syndrome; Exotropia; Female; Frameshift Mutation; Genetic Predisposition to Disease; Homeodomain Proteins; Humans; Lactoylglutathione Lyase; Lysine; Polymerase Chain Reaction; Schizophrenia; Transcription Factors | 2011 |
Association of the ADRA1A gene and the severity of metabolic abnormalities in patients with schizophrenia.
Topics: Adult; Arginine; Cysteine; Female; Gene Frequency; Genetic Association Studies; Humans; Male; Metabolic Syndrome; Middle Aged; Polymorphism, Single Nucleotide; Receptors, Adrenergic, alpha-1; Risk Factors; Schizophrenia; Severity of Illness Index | 2012 |
Schizophrenia shows a unique metabolomics signature in plasma.
Topics: Adult; Aged; Analysis of Variance; Antipsychotic Agents; Arginine; Biomarkers; Case-Control Studies; Female; Genetic Markers; Genetic Predisposition to Disease; Genome-Wide Association Study; Glutamine; Humans; Least-Squares Analysis; Logistic Models; Male; Mass Spectrometry; Metabolomics; Middle Aged; Schizophrenia | 2012 |
Is the arginine-nitric oxide pathway involved in the pathogenesis of schizophrenia?
Topics: Adult; Arginase; Arginine; Blood Chemical Analysis; Case-Control Studies; Female; Humans; Male; Manganese; Middle Aged; Nitric Oxide; Schizophrenia | 2003 |
Analysis of polymorphisms at the tumor suppressor gene p53 (TP53) in contributing to the risk for schizophrenia and its associated neurocognitive deficits.
Topics: Adult; Alleles; Arginine; Chi-Square Distribution; Cognition Disorders; DNA Transposable Elements; Female; Genetic Predisposition to Disease; Genotype; Humans; Male; Polymorphism, Genetic; Proline; Risk; Schizophrenia; Tumor Suppressor Protein p53 | 2004 |
A missense polymorphism (H204R) of a Rho GTPase-activating protein, the chimerin 2 gene, is associated with schizophrenia in men.
Topics: Arginine; Chimerin Proteins; Chromosomes, Human, Pair 7; DNA Primers; Female; Gene Frequency; Genotype; Histidine; Humans; Male; Mutation, Missense; Polymorphism, Genetic; rho GTP-Binding Proteins; Schizophrenia | 2005 |
The lymphotoxin Cys13Arg polymorphism and cognitive functioning in individuals with schizophrenia.
Topics: Adult; Antibodies, Viral; Arginine; Bipolar Disorder; Cognition Disorders; Cysteine; Female; Genetic Predisposition to Disease; Genotype; Herpesvirus 1, Human; Humans; Intelligence; Lymphotoxin-alpha; Male; Middle Aged; Neuropsychological Tests; Polymorphism, Genetic; Schizophrenia | 2007 |
Homozygosity of the interleukin-10 receptor 1 G330R allele is associated with schizophrenia.
Topics: Alleles; Arginine; Case-Control Studies; Female; Gene Frequency; Genetic Linkage; Genotype; Glycine; Homozygote; Humans; Interleukin-10 Receptor alpha Subunit; Male; Models, Genetic; Polymorphism, Single Nucleotide; Schizophrenia | 2007 |
The amino acid L-lysine blocks the disruptive effect of phencyclidine on prepulse inhibition in mice.
Topics: Amino Acid Transport Systems, Basic; Amino Acids; Animals; Arginine; Behavior, Animal; Biological Transport; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Hallucinogens; Lysine; Male; Mice; Nitric Oxide; Phencyclidine; Reflex; Reflex, Startle; Schizophrenia | 2007 |
DAOA ARG30LYS and verbal memory function in schizophrenia.
Topics: Adolescent; Adult; Arginine; Carrier Proteins; Female; Glycine; Humans; Intracellular Signaling Peptides and Proteins; Male; Memory; Middle Aged; Neuropsychological Tests; Polymorphism, Genetic; Schizophrenia; Verbal Learning | 2007 |
Association of missense variants of the PRKC, apoptosis, WT1, regulator (PAWR) gene with schizophrenia.
Topics: 5' Untranslated Regions; Adult; Apoptosis Regulatory Proteins; Arginine; DNA Mutational Analysis; Female; Genetic Predisposition to Disease; Humans; Isoleucine; Male; Methionine; Middle Aged; Mutation, Missense; Polymorphism, Genetic; Proline; Schizophrenia; Sex Factors; Taiwan | 2008 |
Argininosuccinic aciduria in a Finnish woman presenting with psychosis and mental retardation.
Topics: Amino Acid Metabolism, Inborn Errors; Arginine; Argininosuccinic Acid; Female; Humans; Intellectual Disability; Middle Aged; Movement Disorders; Schizophrenia | 1982 |
Elevated platelet calcium mobilization and nitric oxide synthase activity may reflect abnormalities in schizophrenic brain.
Topics: Adult; Amino Acid Oxidoreductases; Arginine; Blood Platelets; Brain; Calcium; Female; Humans; Kinetics; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Schizophrenia; Thrombin | 1995 |
Application of [3H]L-N(G)-nitro-arginine labelling to measure cerebellar nitric oxide synthase in patients with schizophrenia.
Topics: Aged; Arginine; Autoradiography; Cerebellum; Enzyme Inhibitors; Female; Humans; Immunohistochemistry; Male; Middle Aged; NADP; Neurons; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Schizophrenia | 1995 |
Elevated endogenous nitric oxide synthase inhibitor in schizophrenic plasma may reflect abnormalities in brain nitric oxide production.
Topics: Adult; Arginine; Female; Humans; Male; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Schizophrenia | 1996 |
[Determination of guanidinoacetic acid concentration in serum and cerebrospinal fluid].
Topics: Acetates; Adult; Age Factors; Aged; Alcoholism; Arginine; Chromatography, Gel; Dementia; Depression; Epilepsy; Guanidines; Humans; Intracranial Arteriosclerosis; Mental Disorders; Methods; Middle Aged; Neurotic Disorders; Schizophrenia | 1970 |